SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Two Teva insiders sold shares in the open market days after the company…

TEVA PHARMACEUTICAL INDUSTRIES LTD · CLUSTER filed Nov 6, 2026 at 16:03 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Nov 6, 2026 at 16:03 ET

Two Teva insiders sold shares in the open market days after the company reported a Q3 2026 earnings beat and raised guidance. The combined $2.29M in sales is modest relative to Teva's market cap, but the timing and absence of 10b5-1 plans suggest potential profit-taking after the stock's post-earnings strength.

  • Two insiders sold a combined $2.29M in open-market sales on Nov 4-5, 2026
  • Sales followed Teva's Q3 2026 earnings beat (non-GAAP EPS $0.86 vs $0.72 consensus) and raised 2026 revenue outlook
  • Neither sale was executed under a 10b5-1 plan
  • Total sales represent approximately 0.07% of Teva's market cap (estimated ~$3.3B based on ~79M shares at $41.72)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access